Trial Profile
Efficacy of roflumilast in patients with chronic obstructive pulmonary disease
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Nov 2010
Price :
$35
*
At a glance
- Drugs Roflumilast (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Registrational; Therapeutic Use
- 05 Nov 2010 New trial record.